CMV-vectored vaccine (TomegaVax)

N/A

Report date: 2025/03/18 18:13:48

Base Information

Drug NameCMV-vectored vaccine (TomegaVax)
Drug Alias Namecytomegalovirus-vector vaccine (TomegaVax)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTomegavax Inc
China Registration ClassN/A

Develop Information

Active CompaniesTomegavax Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A